When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PGNX - Progenics stiff-arms activist investor opposed to Lantheus merger; shares up 5%
Progenics Pharmaceuticals Inc.
Progenics Pharmaceuticals (PGNX+4.9%) is sending a letter to shareholders urging them to revoke any consents they may have submitted to activist investor Velan Capital LP and to defer sending Velan any consents until they have the opportunity to read the preliminary S-4 detailing the rationale for its acquisition by Lantheus Holdings (LNTH-1.2%) announced a month ago.
More news on: Progenics Pharmaceuticals, Inc., Lantheus Holdings, Inc., Healthcare stocks news, Stocks on the move, Merger & acquisition news,